Patents by Inventor Wolf-Rudiger Ulrich

Wolf-Rudiger Ulrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOPYRIDINE DERIVATIVES USEFUL AS INOS INHIBITORS
    Publication number: 20100317650
    Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: August 3, 2010
    Publication date: December 16, 2010
    Applicant: NYCOMED GmbH
    Inventors: Thomas FUCHSS, Andreas STRUB, Wolf-Rüdiger ULRICH, Christian HESSLINGER, Martin LEHNER, Raimund Külzer, Rainer BOER, Manfrid ELTZE
  • Imidazopyridine derivatives useful as iNOS inhibitors
    Patent number: 7790710
    Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: September 7, 2010
    Assignee: NYCOMED GmbH
    Inventors: Thomas Fuchss, Andreas Strub, Wolf-Rüdiger Ulrich, Christian Hesslinger, Martin Lehner, Raimund Külzer, Rainer Boer, Manfrid Eltze
  • Imidazopyridine Derivatives Useful as iNOS Inhibitors
    Publication number: 20090131399
    Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: March 29, 2006
    Publication date: May 21, 2009
    Applicant: NYCOMED GMBH
    Inventors: Thomas Fuchss, Andreas Strub, Wolf-Rudiger Ulrich, Christian Hesslinger, Martin Lehner, Raimund Kulzer, Rainer Boer, Manfrid Eltze
  • Surfactant protein C esters
    Patent number: 7173009
    Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: February 6, 2007
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Ernst Sturm
  • Alkoxypyridine-derivatives
    Patent number: 7138399
    Abstract: The compounds of formula I in which R1 is 1–4C-alkoxy, A is 1–4C-alkylene, B represents 3H-imidazo[4,5-b]pyridin-2-yl, 3H-imidazo[4,5-b]pyridin-2-yl substituted by R2 and/or R3, 9H-purin-8-yl or 9H-purin-8-yl substituted by R4 and/or R5, are effective iNOS inhibitors.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: November 21, 2006
    Assignee: Altana Pharma AG
    Inventor: Wolf-Rüdiger Ulrich
  • Surfactant protein C esters
    Publication number: 20060148701
    Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
    Type: Application
    Filed: November 28, 2005
    Publication date: July 6, 2006
    Inventors: Wolf-Rudiger Ulrich, Ernst Sturm
  • Surfactant protein C esters
    Patent number: 7022671
    Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: April 4, 2006
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Ernst Sturm
  • Pyrrolidine derivatives as tryptase inhibitors
    Publication number: 20050256171
    Abstract: Compounds of formula 1 in which M, B1, B2, R2, K1 and K2 have the meanings indicated in the description are novel effective tryptase inhibitors.
    Type: Application
    Filed: July 24, 2003
    Publication date: November 17, 2005
    Applicant: Altana Pharma A G
    Inventors: Thomas Martin, Wolf-Rudiger Ulrich
  • Tryptase inhibitors
    Patent number: 6962941
    Abstract: The compounds of formula I in which M, B1, B2, R1, R2, R6, R7, K1 and K2 have the meanings as indicated in the description are novel active tryptase inhibitors.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: November 8, 2005
    Assignee: Altana Pharma AG
    Inventors: Thomas Martin, Wolf-Rüdiger Ulrich
  • Novel alkoxypyridine-derivatives
    Publication number: 20050171125
    Abstract: The compounds of formula I in which R1 is 1-4C-alkoxy, A is 1-4C-alkylene, B represents 3H-imidazo[4,5-b]pyridin-2-yl, 3H-imidazo[4,5-b]pyridin-2-yl substituted by R2 and/or R3, 9H-purin-8-yl or 9H-purin-8-yl substituted by R4 and/or R5, are effective iNOS inhibitors.
    Type: Application
    Filed: March 25, 2003
    Publication date: August 4, 2005
    Applicant: Altana Pharma AG
    Inventor: Wolf-Rudiger Ulrich
  • Diazocine derivatives and their use as tryptase inhibitors
    Patent number: 6924305
    Abstract: Compounds of the formula I, in which B1, B2, R1, R2, R6, R7, K1 and K2 are as defined in the description are novel effective tryp-tase inhibitors.
    Type: Grant
    Filed: January 26, 2002
    Date of Patent: August 2, 2005
    Assignee: Altana Pharma AG
    Inventor: Wolf-Rüdiger Ulrich
  • Process and intermediates for the preparation of imidazopyridines
    Patent number: 6812349
    Abstract: The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: November 2, 2004
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Christian Scheufler, Thomas Fuchss, Jörg Senn-Bilfinger
  • Tryptase inhibitors
    Publication number: 20040176421
    Abstract: Compounds of formula (I) in which M, B1, B2, R1, R2, R6, R7, K1 and K2 have the meanings indicated in the description are novel active tryptase inhibitors.
    Type: Application
    Filed: December 16, 2003
    Publication date: September 9, 2004
    Inventors: Thomas Martin, Wolf-Rudiger Ulrich
  • Tryptase-inhibitors
    Publication number: 20040087792
    Abstract: Compounds of the formula I, wherein M, A1, A2, K1 and K2 have the meanings as indicated in the description are novel effective tryptase inhibitors.
    Type: Application
    Filed: September 4, 2003
    Publication date: May 6, 2004
    Inventors: Thomas Martin, Wolf-Rudiger Ulrich
  • Diazocine derivatives and their use as tryptase inhibitors
    Publication number: 20040072762
    Abstract: Compounds of the formula I, in which B1, B2, R1, R2, R6, R7, K1 and K2 are as defined in the description are novel effective tryp-tase inhibitors.
    Type: Application
    Filed: July 22, 2003
    Publication date: April 15, 2004
    Inventor: Wolf-Rudiger Ulrich
  • Process and intermediates for the preparation of imidazopyridines
    Patent number: 6716990
    Abstract: The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 6, 2004
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Christian Scheufler, Thomas Fuchss, Jörg Senn-Bilfinger
  • Process and intermediates for the preparation of imidazopyridines
    Publication number: 20040059127
    Abstract: The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Application
    Filed: September 23, 2003
    Publication date: March 25, 2004
    Applicants: BYK Gulden Fabrik Lomberg Chemische Fabrik GmbH, Altana Pharma AG
    Inventors: Wolf-Rudiger Ulrich, Christian Scheufler, Thomas Fuchss, Jorg Senn-Bilfinger
  • Tryptase inhibitors
    Patent number: 6673786
    Abstract: A compound of formula I in which M, A1, A2, A3, A4, A5, A6, B1, B2, B3, B4, B5, B6, K1, and K2 are defined herein and are novel effective tryptase-inhibitors.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: January 6, 2004
    Assignee: Altana Pharma AG
    Inventor: Wolf-Rüdiger Ulrich
  • Tryptase inhibitors
    Patent number: 6613769
    Abstract: The invention relates to bifunctional tryptase inhibitors of formula (I) wherein H1 and H2 comprise a Q group and L is a linker of formula and the conformation of the H1, H2 and L groups is such that the groups are separated by a distance of from 20 to 45 Å. Pharmaceutical compositions and crystal forms of the compounds are described in addition to methods for producing and identifying such compounds, as well as the use of such compounds in methods of treating allergic and inflammatory diseases.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: September 2, 2003
    Assignees: Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V., Altana Pharma AG
    Inventors: Wolfram Bode, Luis Moroder, Pedro Jose Barbosa Pereira, Andreas Bergner, Robert Huber, Christian Sommerhoff, Norbert Schaschke, Thomas Bär, Thomas Martin, Josef Stadlwieser, Wolf-Rüdiger Ulrich, Andreas Dominik, Ulrich Thibaut, Daniela Bundschuh, Rolf Beume, Karl-Josef Goebel
  • Process and intermediates for the preparation of imidazopyridines
    Publication number: 20030004358
    Abstract: 1 The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their prepration and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Application
    Filed: June 11, 2002
    Publication date: January 2, 2003
    Inventors: Wolf- Rudiger Ulrich, Christian Scheufler, Thomas Fuchss, Jorg Senn-Bilfinger